医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Clinlogix Launches Asia-Pacific Division with Opening of Offices in Singapore and Tokyo

2016年02月10日 PM09:30
このエントリーをはてなブックマークに追加


 

SPRING HOUSE, Pa.

Leading contract research organization Clinlogix, a full suite provider of clinical development services for medical device and biopharmaceutical customers, announces the launch of their new Asia-Pacific operations with staffed office openings in Singapore and Tokyo, Japan. The expansion into the Asia-Pacific market allows the company to extend and provide its tailored clinical development services via feet-on-the-ground staff with deep, country-specific expertise in both regulatory processes and partnering with clinical study sites to achieve its life science clients’ goals.

Clinlogix Asia Pacific is led by Managing Director Joalin Lim, PhD, who has more than 20 years of clinical and regulatory experience in Japan, China, Australia, Korea and rest of the Asia-Pacific market. Lim’s experience in clinical operations, regulatory affairs, health economics and reimbursement for prior companies such as Quintiles, Covidien and Abbott, among others, position her well for this role with Clinlogix. The team has significant experience in the region managing multi-center cardiovascular medical device clinical studies.

“The launch of the Asia-Pacific division allows Clinlogix to expand and deliver the customized, hands-on, quality clinical research services our global customers have come to expect from our other operations around the globe in the U.S., Europe and South America,” said JeanMarie Markham, Clinlogix CEO. “This will enable us to provide proper training, oversight and further develop our partnerships with clinical sites in these markets, which is vital to ensuring both the regulatory and clinical development success of our clients’ emerging medical technologies.”

About Clinlogix

Clinlogix is a global clinical research organization supporting innovation in the life science industry. Its full suite of clinical research services support the regulatory and clinical development pathway of medical devices, pharmaceuticals, biologics and diagnostics. Clinlogix is the premier partner from proof of concept/discovery, early feasibility/first-in-human, through pivotal and the post-marketing/safety surveillance of client products. The Company delivers global expertise by way of regional office locations in the US – Spring House, Pennsylvania; Europe – London, UK and Mainz, Germany; South America – Medellin, Colombia; and Asia – Singapore and Tokyo, Japan.

Learn more at www.clinlogix.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160210005337/en/

CONTACT

Clinlogix
Michael O’Gorman, 215-855-9054 x 7002
mogorman@clinlogix.com
or
Media:
Brandwidth
Solutions
Debra Harrsch, 267-577-0806
dharrsch@brandwidthsolutions.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • No Dogs Left Behind Meat Market Survivors Coming Home
  • Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease
  • Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据
  • MSCIの調査結果:世界の投資家はパンデミックに対応してESG投資を加速、相互関連するリスクが課題に
  • プロジェクトマネジメント協会のメガトレンド2021が、高まる混乱の力にプロジェクトが対抗できることを明確に